Purchases and Sales Made in Q4 2024 in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during Q4 2024. The information is specifically focused on institutions that hold shares of NEUROCRINE BIOSCIENCES INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-185K- 11.02% |
$20.6M - $25.7M
|
1.49M
$178M
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-192K- 76.04% |
$21.5M - $26.8M
|
60.6K
$7.22M
|
|
Feb 18, 2025
Q4 2024
|
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
Warszawa, R9 |
SELL
|
- |
-193K- 78.16% |
$21.6M - $26.9M
|
54K
$6.43M
|
|
Jan 29, 2025
Q4 2024
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-209K- 30.35% |
$23.4M - $29.2M
|
481K
$57.2M
|
|
Feb 14, 2025
Q4 2024
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-218K- 44.3% |
$24.3M - $30.4M
|
274K
$32.7M
|
|
Feb 14, 2025
Q4 2024
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-219K- 23.27% |
$24.4M - $30.5M
|
721K
$85.8M
|
|
Feb 12, 2025
Q4 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-231K- 27.44% |
$25.8M - $32.2M
|
611K
$72.8M
|
|
Feb 14, 2025
Q4 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-240K- 52.09% |
$26.7M - $33.4M
|
220K
$26.3M
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-257K- 4.99% |
$28.7M - $35.9M
|
4.89M
$583M
|
|
Jan 22, 2025
Q4 2024
|
Robeco Institutional Asset Management B.V.
|
SELL
|
- |
-373K- 96.22% |
$41.6M - $52M
|
14.6K
$1.74M
|
|
Feb 07, 2025
Q4 2024
|
Amundi
Paris, I0 |
SELL
|
- |
-395K- 60.12% |
$44.1M - $55.1M
|
262K
$31.2M
|
|
Feb 14, 2025
Q4 2024
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-455K- 34.53% |
$50.7M - $63.4M
|
862K
$103M
|
|
Feb 14, 2025
Q4 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-457K- 87.18% |
$51M - $63.7M
|
67.2K
$8M
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-618K- 80.99% |
$69M - $86.2M
|
145K
$17.3M
|